MAS revokes licence of Apical Asset Management due to serious breaches of law

29 Jul 2020 - Singapore Business Review
The regulator also reprimanded the firm's CEO and director Yeh Yin Yee and Bernard Cheok Yin. The Monetary Authority of Singapore (MAS) revoked the capital markets services (CMS) licence of Apical Asset Management (AAMPL) after finding serious breaches of MAS’ Anti-Money Laundering/ Contering Financing ...
lse:aml usx:fisi hkex:867

---

PureTech Founded Entity Gelesis Announces Partnership for Commercial Launch of Plenity® in China - PharmiWeb.com

19 Jun 2020 - PharmiWeb.com

hkex:867

---

Gelesis Announces Partnership for Commercial Launch of Plenity® in China - Business Wire

18 Jun 2020 - Business Wire

hkex:867

---

China Medical System Holdings (HKG:867) Has A Rock Solid Balance Sheet - Yahoo Finance

1 May 2020 - Yahoo Finance

hkex:867

---

Here's Why I Think China Medical System Holdings (HKG:867) Is An Interesting Stock - Yahoo Finance

9 Mar 2020 - Yahoo Finance

hkex:1999 hkex:1606 hkex:2007 hkex:1995 hkex:1100 hkex:1111 hkex:1970 hkex:1981 hkex:2002 hkex:1565 hkex:2005 hkex:2016 hkex:1300 hkex:867 hkex:1273 hkex:1990 hkex:1099 hkex:1193 hkex:1270 hkex:2030 hkex:1928

---

CytoSorb Shipment Arrives in Designated Mainland China Hospitals to Treat Cytokine Storm in Critically-ill Patients with COVID-19 Coronavirus Infection - BioSpace

28 Feb 2020 - BioSpace

hkex:1995 hkex:3600 hkex:867

---

CytoSorb Shipment Arrives in China - njbmagazine.com

28 Feb 2020 - njbmagazine.com

hkex:2002 hkex:867

---

CytoSorbents Enters Agreement with China Medical System Holdings Limited to Bring CytoSorb to Mainland China to Treat Critically-ill Patients with COVID-19 Coronavirus Infection - BioSpace

19 Feb 2020 - BioSpace

hkex:1995 hkex:2002 hkex:3600 hkex:867

---

Blue Orca's Short Selling Plan Failed Because the Quality China Medical System (867.HK) Can Withstand Severe Tests

14 Feb 2020 - ACN Newswire
While the world attention is on the fight against Coronavirus in China, Blue Orca is concerned about other things at the same time. This time, this foreign short selling agency aimed at a high-quality Chinese pharmaceutical company.According to Zhitongcaijing APP, recently, Blue Orca targeted China Medical ...
hkex:496 hkex:867 hkex:1717

---

MAS revokes CMS licence of CT Bright Investment

12 Dec 2019 - The Edge Markets
SINGAPORE (Dec 12): The Monetary Authority of Singapore (MAS) has revoked the Capital Markets Services Licence of CT Bright Investment, following numerous breaches of rules and licencing conditions. According to MAS, CTBI did not commence fund management activity within six months of licence issuance, ...
hkex:867

---